The New Frontier: Immunotherapy Combinations

2018-04-20T14:14:59+00:00April 19th, 2018|Hot Topics, News|

At the annual American Association of Cancer Research (AACR) conference, scientists presented new research on what they called “The New Frontier in Lung Cancer” – immunotherapy combinations. The Big Question: Do Combinations Work? If we take the new immunotherapy drugs (like Keytruda, Opdivo, or Tecentriq) that have shown positive results for some people with advanced non-small cell lung cancer (NSCLC) and combine them with another treatment, does the combination work even better? For example, can you add one of those [...]

No announcement available or all announcement expired.